Oral Glutamine Dipeptide Prevents against Prolonged Hypoglycemia Induced by Detemir Insulin in Rats(Pharmacology)

概要

論文の詳細を見る
The role of glutamine dipeptide (GDP) to prevent against prolonged insulin induced hypoglycemia (IIH) in overnight fasted rats was investigated. The glycemia was measured 0, 2, 4, 8, and 10h after an intraperitoneal (i.p.) injection (1U/kg) of Detemir insulin. Because the lowest glycemia was obtained 4h after insulin administration, the experiments were done at this time. The hypoglycemia obtained 4h after insulin injection was partially prevented with increasing oral doses of GDP (1.56, 3.12, 6.25, 12.5mg/kg). The best result was obtained with 12.5mg/kg. However, from this dose (25.0, 50.0, 100.0mg/kg), the values of glycemia progressively decreased (p<0.05). The effect of GDP to prevent prolonged IIH was mediated, partly at least, by an intensification of liver gluconeogenesis. Moreover, the increased portal availability of GDP, L-alanine and L-glutamine after GDP administration also contributed to the IIH prevention, since the rate of gluconeogenesis progressively augmented with the infusion of increasing concentrations of these substances. However, after getting the maximal value, the rate of liver gluconeogenesis decreased (p<0.05) if a more elevated concentration of L-alanine or L-glutamine was infused. On the other hand, the liver gluconeogenesis during the infusion of increasing concentrations of GDP was unchanged. Because, GDP did not directly inhibit liver gluconeogenesis, but an inhibition of this metabolic pathway was observed with low ammonia concentrations (from 0.062mM) it is possible that the ammonia from the catabolism of GDP by extra hepatic tissues could inhibit liver gluconeogenesis. This mechanism could help to explain the lower glycemia obtained with more elevated doses of oral GDP.
公益社団法人日本薬学会の論文
2009-02-01

Oral Glutamine Dipeptide Prevents against Prolonged Hypoglycemia Induced by Detemir Insulin in Rats(Pharmacology)

スポンサーリンク

概要

著者

関連論文

スポンサーリンク